226 related articles for article (PubMed ID: 38203330)
21. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
22. Molecular Docking and Network Pharmacology Interaction Analysis of Gingko Biloba (EGB761) Extract with Dual Target Inhibitory Mechanism in Alzheimer's Disease.
Singh M; Jindal D; Kumar R; Pancham P; Haider S; Gupta V; Mani S; R R; Tiwari RK; Chanda S
J Alzheimers Dis; 2023; 93(2):705-726. PubMed ID: 37066913
[TBL] [Abstract][Full Text] [Related]
23. Specific miRNAs are associated with human cancer cachexia in an organ-specific manner.
Krauss T; Heisz S; Honecker J; Prokopchuk O; Martignoni M; Janssen KP; Claussnitzer M; Hauner H; Seeliger C
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1381-1394. PubMed ID: 37021483
[TBL] [Abstract][Full Text] [Related]
24. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
[TBL] [Abstract][Full Text] [Related]
25. The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis.
Freire PP; Fernandez GJ; Cury SS; de Moraes D; Oliveira JS; de Oliveira G; Dal-Pai-Silva M; Dos Reis PP; Carvalho RF
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013615
[TBL] [Abstract][Full Text] [Related]
26. Identification of phytochemical compounds of
Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L
Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation.
Xiao B; Li J; Qiao Z; Yang S; Kwan HY; Jiang T; Zhang M; Xia Q; Liu Z; Su T
J Ethnopharmacol; 2023 Dec; 317():116852. PubMed ID: 37390879
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as potential therapeutic targets for muscle wasting during cancer cachexia.
Sannicandro AJ; McDonagh B; Goljanek-Whysall K
Curr Opin Clin Nutr Metab Care; 2020 May; 23(3):157-163. PubMed ID: 32073414
[TBL] [Abstract][Full Text] [Related]
29. Application of Kampo medicines for the palliation of cancer cachexia.
Ohsawa M; Makino T; Takimoto Y; Inui A
Neuropeptides; 2021 Dec; 90():102188. PubMed ID: 34488048
[TBL] [Abstract][Full Text] [Related]
30. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
31. Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients.
Yan L; Jiang MY; Fan XS
J Ethnopharmacol; 2023 Dec; 317():116773. PubMed ID: 37308028
[TBL] [Abstract][Full Text] [Related]
32. Prediction of potential cancer-related molecular targets of North African plants constituents using network pharmacology-based analysis.
Shawky E
J Ethnopharmacol; 2019 Jun; 238():111826. PubMed ID: 30910579
[TBL] [Abstract][Full Text] [Related]
33. The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world.
Cheng KC; Li YX; Cheng JT
Curr Pharm Des; 2012; 18(31):4819-26. PubMed ID: 22632862
[TBL] [Abstract][Full Text] [Related]
34. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
35. The Role of Natural Products in the Improvement of Cancer-Associated Cachexia.
Han Y; Kim HI; Park J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240117
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
37. Identification of Fangji Huangqi Tang as a potential herbal formula for Sjogren syndrome treatment via network pharmacology and experimental validation.
Shao Y; Hu J; Wang S; Jiang H; Miao G; Li C; Zhang J; Xu Y
Chem Biol Drug Des; 2023 Dec; 102(6):1435-1447. PubMed ID: 37640538
[TBL] [Abstract][Full Text] [Related]
38. Exploring underlying mechanism of artesunate in treatment of acute myeloid leukemia using network pharmacology and molecular docking.
Tao Y; Li W; Yang J; Xue T; Wang Y; Dong X; Xu H; Ren J; Lu J
Clin Transl Oncol; 2023 Aug; 25(8):2427-2437. PubMed ID: 36952106
[TBL] [Abstract][Full Text] [Related]
39. Analysis of molecular networks and targets mining of Chinese herbal medicines on anti-aging.
Jiang QY; Zheng MS; Yang XJ; Sun XS
BMC Complement Altern Med; 2016 Dec; 16(1):520. PubMed ID: 28031022
[TBL] [Abstract][Full Text] [Related]
40. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
